Published in Case Rep Obstet Gynecol on December 22, 2013
The future is now: frontiers on display at Yale-NAVBO cardiovascular inflammation and remodeling symposium 2014. Yale J Biol Med (2014) 0.75
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation (2010) 2.45
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation (2010) 2.41
Peripartum cardiomyopathy: Causes, diagnosis, and treatment. Cleve Clin J Med (2009) 1.93
Saving mothers' lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. BJOG (2011) 1.24
Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet (2011) 1.19
Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol (2011) 1.15
Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97
Inflammatory markers and cytokines in peripartum cardiomyopathy: a delicate balance. Expert Opin Ther Targets (2010) 0.88
Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment. Trends Cardiovasc Med (2011) 0.85